Chemistry Wealth Management LLC Buys 14,711 Shares of T. Rowe Price Capital Appreciation Equity ETF $TCAF

Chemistry Wealth Management LLC boosted its stake in T. Rowe Price Capital Appreciation Equity ETF (NYSEARCA:TCAF) by 9.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 178,235 shares of the company’s stock after purchasing an additional 14,711 shares during the quarter. T. Rowe Price Capital Appreciation Equity ETF comprises about 1.3% of Chemistry Wealth Management LLC’s holdings, making the stock its 15th biggest position. Chemistry Wealth Management LLC’s holdings in T. Rowe Price Capital Appreciation Equity ETF were worth $6,812,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Raymond James Financial Inc. raised its holdings in shares of T. Rowe Price Capital Appreciation Equity ETF by 9.8% during the third quarter. Raymond James Financial Inc. now owns 5,878,165 shares of the company’s stock valued at $221,607,000 after purchasing an additional 526,810 shares during the period. Commonwealth Equity Services LLC boosted its position in shares of T. Rowe Price Capital Appreciation Equity ETF by 17.1% during the 3rd quarter. Commonwealth Equity Services LLC now owns 4,993,270 shares of the company’s stock worth $188,246,000 after purchasing an additional 730,560 shares in the last quarter. Osaic Holdings Inc. grew its stake in shares of T. Rowe Price Capital Appreciation Equity ETF by 16.0% in the 2nd quarter. Osaic Holdings Inc. now owns 2,788,479 shares of the company’s stock valued at $98,385,000 after buying an additional 384,217 shares during the period. Baird Financial Group Inc. grew its stake in shares of T. Rowe Price Capital Appreciation Equity ETF by 7.7% in the 2nd quarter. Baird Financial Group Inc. now owns 2,725,494 shares of the company’s stock valued at $96,155,000 after buying an additional 195,072 shares during the period. Finally, JPMorgan Chase & Co. increased its position in T. Rowe Price Capital Appreciation Equity ETF by 3,475.1% in the 3rd quarter. JPMorgan Chase & Co. now owns 2,076,667 shares of the company’s stock valued at $78,290,000 after buying an additional 2,018,580 shares in the last quarter.

T. Rowe Price Capital Appreciation Equity ETF Stock Performance

TCAF stock opened at $36.07 on Friday. The stock’s 50 day simple moving average is $37.68 and its 200 day simple moving average is $37.91. T. Rowe Price Capital Appreciation Equity ETF has a fifty-two week low of $28.28 and a fifty-two week high of $39.34. The company has a market cap of $6.11 billion, a P/E ratio of 29.44 and a beta of 0.91.

T. Rowe Price Capital Appreciation Equity ETF Company Profile

The T. Rowe Price Capital Appreciation Equity ETF (TCAF) is an exchange-traded fund. The fund’s investment portfolio concentrates primarily on large cap equity. TCAF is an actively managed fund that pursues higher quality stocks of US large-cap companies that are perceived to have above average potential for capital growth.